302 related articles for article (PubMed ID: 29631562)
21. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.
Molinari C; Iorio P; Medri L; Ballardini M; Guiducci G; Cremonini AM; Cerasoli S; Riccioni L; Faedi M; Mariani GA; Zoli W; Silvestrini R; Calistri D
Int J Mol Med; 2010 Jan; 25(1):145-51. PubMed ID: 19956913
[TBL] [Abstract][Full Text] [Related]
22. Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas.
Feller C; Felix M; Weiss T; Herold-Mende C; Zhang F; Kockmann T; Sahm F; Aebersold R; von Deimling A; Reuss DE
Acta Neuropathol; 2020 Jan; 139(1):211-213. PubMed ID: 31773240
[No Abstract] [Full Text] [Related]
23. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.
Sonabend AM; Lesniak MS
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis.
Otani R; Mukasa A; Uzuka T; Higuchi F; Matsuda H; Nomura M; Tanaka S; Kim P; Ueki K
J Neurooncol; 2021 Sep; 154(2):221-228. PubMed ID: 34328582
[TBL] [Abstract][Full Text] [Related]
25. Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.
Li YX; Aibaidula A; Shi Z; Chen H; Li KK; Chung NY; Yang RR; Chan DT; Poon WS; Lee KLR; Mao Y; Wu J; Chan AK; Zhou L; Ng HK
J Neurooncol; 2018 Sep; 139(2):307-322. PubMed ID: 29761369
[TBL] [Abstract][Full Text] [Related]
26. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
27. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling and subgroup identification of oligodendrogliomas.
Huang H; Okamoto Y; Yokoo H; Heppner FL; Vital A; Fevre-Montange M; Jouvet A; Yonekawa Y; Lazaridis EN; Kleihues P; Ohgaki H
Oncogene; 2004 Aug; 23(35):6012-22. PubMed ID: 15208679
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
[TBL] [Abstract][Full Text] [Related]
30. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
[TBL] [Abstract][Full Text] [Related]
31. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
32. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
Cairncross G; Jenkins R
Cancer J; 2008; 14(6):352-7. PubMed ID: 19060598
[TBL] [Abstract][Full Text] [Related]
33. Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas.
Senetta R; Trevisan E; Rudà R; Maldi E; Molinaro L; Lefranc F; Chiusa L; Lanotte M; Soffietti R; Cassoni P
J Neuropathol Exp Neurol; 2009 Apr; 68(4):425-31. PubMed ID: 19287309
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
[TBL] [Abstract][Full Text] [Related]
35. ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties.
Hubstenberger A; Labourdette G; Baudier J; Rousseau D
Exp Cell Res; 2008 Sep; 314(15):2870-83. PubMed ID: 18639545
[TBL] [Abstract][Full Text] [Related]
36. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
Nigro JM; Takahashi MA; Ginzinger DG; Law M; Passe S; Jenkins RB; Aldape K
Am J Pathol; 2001 Apr; 158(4):1253-62. PubMed ID: 11290543
[TBL] [Abstract][Full Text] [Related]
37. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
38. Static and dynamic
Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
[TBL] [Abstract][Full Text] [Related]
39. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiles associated with treatment response in oligodendrogliomas.
French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA
Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
